Search results
It's taxing times for electoral bond buyers after Supreme Court's Feb verdict - ETCFO
The Economic Times· 2 days agoProminent companies such as Infosys, Embassy Group, Megha Engineering, Aditya Birla Group, JSW...
Morning Scan: All the big stories to get you started for the day
CNBC Awaaz· 3 days agoDomestic institutional investors, which includes mutual funds, banks, insurers and financial...
It's taxing times for electoral bond buyers after Supreme Court's Feb verdict
The Economic Times· 3 days agoThe 1,300 entities that purchased electoral bonds to make political donations potentially face...
It’s Taxing Times for Poll Bond Buyers After SC’s Feb Verdict
The Economic Times· 3 days agoThe 1,300 entities that purchased electoral bonds to make political donations potentially face...
Ahead of Market: 10 things that will decide D-Street action on Monday
The Economic Times· 3 days agoHaving moved up sharply Nifty is currently facing hurdles at the resistance of 24,000-24,100 levels....
PLI scheme for obesity, diabetes drugs likely by 2026: Report
Business Today· 5 days agoIndian pharma companies such as Dr. Reddy's Laboratories, Lupin, Zydus Cadila, and Sun Pharma are...
Stock market update: Nifty Pharma index advances 1.11%
The Economic Times· 5 days agoThe Nifty Pharma index closed 1.11 per cent up at 19731.55.
Lupin fined 40 Million Euros by EU court for anti-competitive drug deal | India Infoline
India Infoline· 5 days agoLupin must pay 40 million euros plus accrued interest to the European Commission.
India plans incentives for diabetes, obesity drug makers in 2026, government official says - ET...
The Economic Times· 5 days agoBengaluru: India is planning to offer incentives to promote local manufacturing of GLP-1 drugs used...
European Court of Justice upholds 40 million Euro fine on Lupin | India Infoline
India Infoline· 5 days agoThe European Court of Justice confirmed the European Commission’s decision to impose a 40 million euro fine on Lupin Limited. This decision was made in connection with a patent ...